Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.

What was recalled

Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 62037-831-01

Recalling firm: Teva Pharmaceuticals USA
NDC code: 62037-831-01
Origin: PA, United States
Initiated by: Voluntary: Firm initiated
FDA recall number: D-0129-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Metoprolol recalls

See all

Class II · Moderate risk Ongoing Apr 27, 2026